Company Overview of Applied Immune Technologies Ltd.
Applied Immune Technologies Ltd. engages in the development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications in pathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel. As of January 27, 2016, Applied Immune Technologies Ltd. operates as a subsidiary of Adicet Bio, Inc.
Gutwirth Industrial Park
Founded in 2006
972 4 8122216
972 4 8122294
Key Executives for Applied Immune Technologies Ltd.
Applied Immune Technologies Ltd. Key Developments
Similar Private Companies By Industry
|Beta-O2 Technologies Ltd.||Middle East/Africa|
|CoralTech Ltd.||Middle East/Africa|
|Alfred Mann Institue at the Technion Ltd.||Middle East/Africa|
|cCAM Biotherapeutics Ltd||Middle East/Africa|
|IDEA Bio-Medical Ltd.||Middle East/Africa|
Recent Private Companies Transactions
January 27, 2016
To contact Applied Immune Technologies Ltd., please visit www.tcrl.co.il. Company data is provided by Capital IQ. Please use this form to report any data issues.